These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 15940622)

  • 1. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.
    Maul J; Loddenkemper C; Mundt P; Berg E; Giese T; Stallmach A; Zeitz M; Duchmann R
    Gastroenterology; 2005 Jun; 128(7):1868-78. PubMed ID: 15940622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
    Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
    Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.
    Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H
    Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.
    Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG
    J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    Lord JD; Shows DM; Chen J; Thirlby RC
    PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.
    Li Z; Arijs I; De Hertogh G; Vermeire S; Noman M; Bullens D; Coorevits L; Sagaert X; Schuit F; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2010 Aug; 16(8):1299-310. PubMed ID: 20196149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera.
    Zhao WB; Li Y; Liu X; Zhang LY; Wang X
    Chin Med J (Engl); 2008 Sep; 121(18):1781-6. PubMed ID: 19080357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral and Intestinal T-regulatory Cells are Upregulated in Children with Inflammatory Bowel Disease at Onset of Disease.
    Sznurkowska K; Żawrocki A; Sznurkowski J; Zieliński M; Landowski P; Plata-Nazar K; Iżycka-Świeszewska E; Trzonkowski P; Szlagatys-Sidorkiewicz A; Kamińska B
    Immunol Invest; 2016 Nov; 45(8):787-796. PubMed ID: 27759462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.
    Tsunemi S; Iwasaki T; Imado T; Higasa S; Kakishita E; Shirasaka T; Sano H
    AIDS; 2005 Jun; 19(9):879-86. PubMed ID: 15905668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
    Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
    Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
    Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
    Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.
    Lorea Baroja M; Kirjavainen PV; Hekmat S; Reid G
    Clin Exp Immunol; 2007 Sep; 149(3):470-9. PubMed ID: 17590176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation.
    Makita S; Kanai T; Nemoto Y; Totsuka T; Okamoto R; Tsuchiya K; Yamamoto M; Kiyono H; Watanabe M
    J Immunol; 2007 Apr; 178(8):4937-46. PubMed ID: 17404275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.
    Vieira PL; Christensen JR; Minaee S; O'Neill EJ; Barrat FJ; Boonstra A; Barthlott T; Stockinger B; Wraith DC; O'Garra A
    J Immunol; 2004 May; 172(10):5986-93. PubMed ID: 15128781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.
    Wu YE; Peng WG; Cai YM; Zheng GZ; Zheng GL; Lin JH; Zhang SW; Li K
    Int J Infect Dis; 2010 Sep; 14(9):e815-22. PubMed ID: 20655262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.